📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
MIDHANI Declares Interim Dividend of Rs. 0.85 Per Share for FY 2025-26
Mishra Dhatu Nigam Limited (MIDHANI) has announced an interim dividend of Rs. 0.85 per equity share for the financial year 2025-26. This payout represents 8.50% of the face value of Rs. 10 per share. The Board of Directors approved the dividend in a meeting held on March 13, 2026. The company has established March 19, 2026, as the record date to identify eligible shareholders for the payment.
Key Highlights
Interim dividend of Rs. 0.85 per equity share declared for FY 2025-26
Dividend payout is 8.50% based on a face value of Rs. 10 per share
Record date for dividend entitlement is set for March 19, 2026
Board meeting concluded on March 13, 2026, at 1250 hrs
💼 Action for Investors
Investors interested in the dividend should ensure they hold the stock before the ex-dividend date. Long-term investors should evaluate this payout in the context of the company's overall yield and performance in the defense sector.
Pidilite Shareholders Approve Dr. Naushad Forbes as Independent Director with 98.4% Majority
Pidilite Industries has announced the successful passage of a special resolution to appoint Dr. Naushad Forbes as an Independent Director. The resolution was approved via postal ballot with a significant majority of 98.40% of the total votes cast. While the promoter group voted entirely in favor, public institutional investors showed a 92.82% approval rate, with approximately 7.18% voting against. This appointment is expected to strengthen the company's board governance and strategic oversight.
Key Highlights
Special resolution for Dr. Naushad Forbes' appointment passed with a 98.40% majority of votes cast.
Total votes polled reached 88.83 crore, representing 87.28% of the total outstanding shares.
Promoter and Promoter Group cast 100% of their 68.92 crore votes in favor of the resolution.
Public Institutional investors cast 18.26 crore votes in favor (92.82%) and 1.41 crore votes against (7.18%).
The resolution is deemed approved as of March 12, 2026, following the conclusion of the e-voting period.
💼 Action for Investors
Investors should view this as a positive governance move, as the addition of a high-profile independent director like Dr. Naushad Forbes enhances board quality. No immediate trading action is required as this is a routine but positive administrative update.
Bharat Seats Shareholders Approve Material Related Party Transactions with Maruti Suzuki
Bharat Seats Limited has announced that its shareholders have approved material related party transactions with Maruti Suzuki India Limited through a postal ballot. The resolution was passed with the requisite majority as per the scrutinizer's report dated March 13, 2026. This approval is vital for the company as Maruti Suzuki is its primary customer and a joint venture partner. The formalization of these transactions ensures business continuity and operational stability for the upcoming periods.
Key Highlights
Shareholders approved material related party transactions with Maruti Suzuki India Limited
Resolution passed with requisite majority via postal ballot process initiated on February 03, 2026
Scrutinizer's report confirming the voting results was submitted on March 13, 2026
Ensures continued business relationship with the company's largest revenue contributor
💼 Action for Investors
Investors should view this as a positive development that secures the company's primary revenue stream. No immediate action is required, but keep an eye on quarterly margins from these transactions.
Snowman Logistics to Establish 6,500-Pallet Cold Storage Facility in Patna
Snowman Logistics is expanding its footprint in Eastern India with a new 6,500-pallet temperature-controlled facility in Patna. Developed under a Built-to-Suit (BTS) model with Nahar Group, the facility is scheduled to be operational by January 2027. The site will offer a wide temperature range from -25°C to +20°C, catering to high-growth sectors like pharmaceuticals, QSR, and seafood. This expansion builds upon the company's existing nationwide capacity of 160,230 pallets across 22 cities.
Key Highlights
New 6,500-pallet capacity facility being developed in Patna, Bihar
Projected to be operational by January 2027 under a Built-to-Suit (BTS) model
Temperature range of -25°C to +20°C to serve pharma, ice cream, and QSR segments
Expands total network capacity beyond the current 160,230 pallets across 22 cities
💼 Action for Investors
Investors should monitor the company's ability to maintain high utilization rates as it expands into the Eastern India market. The BTS model is a capital-efficient way to grow, making this a positive long-term development for the stock.
Bharat Seats Shareholders Approve Material Related Party Transactions with Maruti Suzuki
Bharat Seats Limited has announced the successful passage of an ordinary resolution via postal ballot to approve material related party transactions with Maruti Suzuki India Limited. The resolution received overwhelming support, with 99.01% of the votes cast in favor. A total of 1,081,324 votes were polled, ensuring the continuity of business operations with its primary customer and partner. This approval is critical as Maruti Suzuki is a major stakeholder and the primary client for the company's seating products.
Key Highlights
Shareholders approved material related party transactions with Maruti Suzuki India Limited via postal ballot.
The resolution was passed with a 99.01% majority, representing 1,070,644 votes in favor.
A total of 1,081,324 votes were polled during the e-voting period ending March 12, 2026.
The promoter group, holding 46.88 million shares, was an interested party and did not participate in the vote.
💼 Action for Investors
This is a positive development for business continuity; investors should maintain their positions as the core revenue stream remains secure through this approved partnership.
Bharat Seats Shareholders Approve Material Related Party Transactions with Maruti Suzuki
Bharat Seats Limited has successfully passed an ordinary resolution via postal ballot to approve material related party transactions with Maruti Suzuki India Limited. The resolution received overwhelming support with 99.01% of the votes cast in favor. Although the total turnout was low at 1.72% of total shares, this is due to the promoter group (holding 46.88 million shares) being interested parties and thus ineligible to vote. This approval is critical as it formalizes the ongoing business relationship with the company's primary customer.
Key Highlights
Shareholders approved material related party transactions with Maruti Suzuki India Limited with a 99.01% majority.
A total of 1,070,644 votes were cast in favor of the resolution, while only 10,680 votes were against.
The promoter group, holding 46,888,358 shares, was identified as an interested party for this resolution.
Public institutional participation stood at 46.56% of their segment, while non-institutional public turnout was 6.40%.
The voting process was conducted via e-voting from February 11 to March 12, 2026.
💼 Action for Investors
Investors should take this as a positive sign of business continuity with Maruti Suzuki, the company's largest client. No immediate action is required, but keep an eye on the scale of these transactions in upcoming quarterly reports.
Aurobindo Pharma Faces ₹77.6 Cr GST Demand and Equal Penalty; To Appeal in GSTAT
Aurobindo Pharma has received an order from the GST Appellate Authority confirming a tax demand of ₹77.61 crore and an equivalent penalty of ₹77.61 crore. The dispute pertains to alleged excess IGST refunds and non-reversal of Input Tax Credit (ITC) for the period between July 2017 and March 2020. While the authority dropped the interest demand on ITC reversal, the primary tax and penalty were upheld. The company has already paid ₹23.72 crore under protest and intends to challenge the ruling at the GST Appellate Tribunal (GSTAT).
Key Highlights
GST demand of ₹77.61 crore confirmed along with a matching penalty of ₹77.61 crore.
Issues involve excess IGST refund (CIF vs FOB) and non-reversal of ITC under Rule 37 for FY 2017-2020.
Company has already deposited ₹23.72 crore under protest and reversed ₹8.78 crore in ITC.
Appellate Authority dropped the demand for interest on ITC reversal while upholding other charges.
Aurobindo Pharma plans to file an appeal before the Goods and Services Tax Appellate Tribunal (GSTAT).
💼 Action for Investors
Investors should monitor the outcome of the GSTAT appeal as the total potential liability exceeds ₹150 crore. While the company maintains there is no material impact, persistent tax litigation can weigh on short-term sentiment.
Banco Products Declares Second Interim Dividend of Rs 8 Per Share (400%)
Banco Products (India) Limited has announced a Second Interim Dividend of Rs 8 per equity share for the financial year 2025-26. This payout represents 400% of the face value of Rs 2 per share. The company has established March 19, 2026, as the record date to determine shareholder eligibility. Payments are scheduled to be disbursed starting from March 25, 2026.
Key Highlights
Second Interim Dividend declared at Rs 8 per equity share
Dividend payout represents 400% of the face value of Rs 2
Record date for eligibility is fixed as March 19, 2026
Dividend payment to commence on or after March 25, 2026
💼 Action for Investors
Investors seeking dividend income should ensure they hold the stock before the ex-dividend date to qualify for the Rs 8 per share payout. The substantial dividend yield reflects the company's commitment to returning capital to shareholders.
Banco Products Declares Second Interim Dividend of Rs 8 Per Share (400%)
Banco Products (India) Limited has declared a second interim dividend of Rs 8 per equity share for the financial year 2025-26. This payout represents 400% of the face value of Rs 2 per share. The company has established March 19, 2026, as the record date for determining shareholder eligibility. The dividend payment is scheduled to be disbursed on or after March 25, 2026.
Key Highlights
Second interim dividend of Rs 8 per share declared for FY 2025-26
Dividend payout is 400% based on a face value of Rs 2 per share
Record date for eligibility is fixed as March 19, 2026
Payment to be processed on or after March 25, 2026
💼 Action for Investors
Investors interested in the dividend should ensure they hold the shares before the ex-dividend date (typically one day prior to the record date) to be eligible for the Rs 8 per share payout.
Banco Products Declares Second Interim Dividend of Rs 8 Per Share (400%)
Banco Products (India) Limited has declared a second interim dividend of Rs 8 per equity share for the financial year 2025-26. This payout represents 400% of the face value of Rs 2 per share. The company has fixed March 19, 2026, as the record date to identify eligible shareholders. The dividend distribution is scheduled to begin on or after March 25, 2026, indicating a healthy cash position and commitment to shareholder returns.
Key Highlights
Second interim dividend of Rs 8 per equity share declared for FY 2025-26.
Dividend payout represents 400% of the face value of Rs 2 per share.
Record date for determining shareholder entitlement is March 19, 2026.
Payment of the dividend will be processed on or after March 25, 2026.
💼 Action for Investors
Investors seeking dividend income should ensure they hold the stock before the record date of March 19, 2026, to be eligible for the Rs 8 per share payout.
Krystal Integrated Services Secures Rs 364 Crore Facility Management Order
Krystal Integrated Services Limited has been awarded a major contract worth approximately Rs 364 Crores by Tamil Nadu Medical Services Corporation Limited. The project involves providing housekeeping, security, and related services to various government medical institutions across Tamil Nadu. This domestic contract has a tenure of three years, ensuring steady revenue inflow for the company. The scope includes institutions under the Directorate of Medical and Rural Health Services and the Commissionerate of Indian Medicine and Homeopathy.
Key Highlights
Awarded a 3-year contract worth approximately Rs 364 Crores
Client is Tamil Nadu Medical Services Corporation Limited
Services include housekeeping and security for government medical institutions
Contract awarded in the ordinary course of business providing long-term revenue visibility
💼 Action for Investors
This large order significantly boosts the company's order book and provides long-term revenue visibility. Investors should monitor the impact on operating margins as the contract is executed over the next three years.
Hind Rectifiers to Incorporate Wholly Owned Subsidiary in UAE for ₹37.65 Lakhs
Hind Rectifiers Limited (HIRECT) has approved the incorporation of a 100% wholly owned subsidiary in the United Arab Emirates, specifically within the Dubai International Financial Centre (DIFC). The company will invest 150,000 AED (approximately ₹37.65 lakhs) as cash consideration for the initial capital contribution. This new entity will function strictly as a holding company to manage current and future international subsidiaries rather than engaging in direct commercial operations. This move is part of HIRECT's broader global expansion strategy to streamline oversight and management of its overseas investments.
Key Highlights
Approved incorporation of a 100% wholly owned subsidiary in the United Arab Emirates (UAE)
Initial cash investment of 150,000 AED, equivalent to approximately ₹37,65,819
The entity will serve as a holding company for all existing and future overseas subsidiaries
The subsidiary will be based in the Dubai International Financial Centre (DIFC) to facilitate global expansion
The entity will not undertake any direct operational or commercial business activities initially
💼 Action for Investors
Investors should view this as a strategic step toward international expansion and improved corporate structuring for global operations. Monitor future announcements regarding specific overseas projects or acquisitions that this holding company will manage.
Repco Home Finance Allots NCDs Worth Rs 125 Crore at 8.40% Coupon
Repco Home Finance has successfully allotted 12,500 Non-Convertible Debentures (NCDs) to raise Rs 125 crore via a private placement on the BSE platform. The NCDs carry a fixed coupon rate of 8.40% per annum with interest payable monthly, which is a standard rate for the housing finance sector. The tenure is 36 months, featuring a staggered redemption schedule where 34% is repaid in the first year and 33% in each of the subsequent two years. This fundraise will likely be utilized to support the company's ongoing lending operations and strengthen its liquidity position.
Key Highlights
Total fundraise of Rs 125 crore through 12,500 NCDs of Rs 1 lakh face value each
Fixed coupon rate of 8.40% per annum with a monthly interest payment frequency
Staggered redemption: 34% in March 2027, 33% in March 2028, and 33% in March 2029
Secured by hypothecated assets with a minimum security cover of 1.10 times
Additional interest of 2.00% p.a. over the coupon rate in case of default
💼 Action for Investors
Investors should view this as a routine but positive liquidity management exercise that supports loan growth. Monitor the company's net interest margins (NIMs) to see how effectively this 8.40% cost of debt is being deployed.
Britannia Clarifies No Significant Disruption from Industrial Gas Supply Issues
Britannia Industries has issued a formal clarification under Regulation 30(11) to address market rumors regarding potential operational disruptions due to industrial gas supply issues linked to the Middle East conflict. The company confirmed that it has not experienced any significant impact on manufacturing and maintains adequate finished goods inventory across its network. Additionally, the company highlighted its operational flexibility, utilizing multiple fuel sources including LPG, PNG, and Biomass, which allows for technical adjustments if supply chains tighten. This proactive disclosure aims to stabilize investor sentiment amid geopolitical uncertainties.
Key Highlights
No significant disruption experienced at manufacturing facilities due to industrial gas supply issues.
Adequate levels of finished goods inventory maintained across the entire supply chain to meet market demand.
Operational flexibility to switch between fuel types including LPG, PNG, Biomass, and Liquid fuels.
Management expressed confidence in the Government of India's steps to address potential industrial challenges.
💼 Action for Investors
Investors should take comfort in the company's multi-fuel capabilities and healthy inventory levels which mitigate supply chain risks. No change in investment thesis is required as the rumors of disruption have been officially refuted.
Canara HSBC Life Allots NCDs Worth ₹250 Crore at 8.15% Coupon Rate
Canara HSBC Life Insurance has successfully allotted 25,000 unsecured, subordinated non-convertible debentures (NCDs) on a private placement basis. The total fundraise amounts to ₹250 crore, with each debenture having a face value of ₹1 lakh. These instruments carry a coupon rate of 8.15% per annum and have a tenure of 10 years, though the company holds a call option after 5 years. This capital infusion is likely intended to strengthen the company's solvency margin and support long-term business growth.
Key Highlights
Allotment of 25,000 unsecured, subordinated NCDs aggregating to ₹250 crore
Fixed coupon rate of 8.15% per annum with annual interest payment schedules starting March 2027
Instrument tenure of 10 years with a call option available to the issuer after 5 years
The NCDs are listed on the National Stock Exchange (NSE) for liquidity
Default penalty includes an additional 2% interest rate per annum until the default is cured
💼 Action for Investors
Investors should view this as a positive move to bolster the company's Tier-II capital and solvency ratios. Monitor how these funds are deployed to drive premium growth and market share in the competitive life insurance sector.
Puravankara Launches 'Northern Lights' Residential Project in Bengaluru Across 3 Phases
Puravankara Limited's associate, KVN Property Holdings LLP, has received KRERA registration for its new residential project, 'Northern Lights by Puravankara KVN'. Located in Bengaluru's Hitech, Defense and Aerospace Park, the project is being launched in three distinct phases starting March 14, 2026. This launch signifies the company's continued expansion in the high-growth Bengaluru residential market. The project caters specifically to the domestic market and follows all regulatory approvals from the Karnataka Real Estate Regulatory Authority.
Key Highlights
Launch of 'Northern Lights by Puravankara KVN' residential project in Bengaluru North on March 14, 2026
Project consists of three distinct phases (Phase 1, 2, and 3) with KRERA registration numbers obtained for all
Strategically located at Plot No. R-12 of Hitech, Defense and Aerospace Park, Bagalur Village
Project is being executed through KVN Property Holdings LLP, an associate of Puravankara Limited
💼 Action for Investors
Investors should monitor the pre-sales velocity and booking numbers for this project as it will be a key driver for future revenue and cash flow. The strategic location in a tech and aerospace hub is likely to attract strong demand from the domestic market.
NGL Fine-Chem Credit Rating Outlook Upgraded to 'Stable' from 'Negative'
CRISIL Ratings has revised the outlook on NGL Fine-Chem Limited's long-term bank loan facilities to 'Stable' from 'Negative'. While the outlook has improved, the long-term rating itself has been reaffirmed at 'CRISIL BBB+'. Additionally, the company's short-term rating was reaffirmed at 'CRISIL A2'. This revision indicates a stabilization in the company's credit profile and a reduced risk of a rating downgrade in the near term.
Key Highlights
Outlook on long-term bank facilities revised to 'Stable' from 'Negative'
Long-term credit rating reaffirmed at 'CRISIL BBB+'
Short-term credit rating reaffirmed at 'CRISIL A2'
Rating action communicated by CRISIL Ratings on March 12, 2026
💼 Action for Investors
Investors should view the outlook upgrade as a sign of improving financial stability; however, continue to monitor quarterly earnings for sustained operational growth.
Puravankara Launches 3-Phase Residential Project 'Northern Lights' in Bengaluru
Puravankara Limited has announced the launch of its new residential project, 'Northern Lights by Puravankara KVN', located in the Hitech, Defense and Aerospace Park in Bengaluru. The company has successfully secured RERA registration for all three phases of the project from the Karnataka Real Estate Regulatory Authority. The official launch is scheduled for March 14, 2026, targeting the domestic residential market. This project launch is part of the company's ongoing expansion in the high-growth Bengaluru North corridor.
Key Highlights
Launch of 'Northern Lights by Puravankara KVN' spanning three distinct phases (Phase 1, 2, and 3).
Received KRERA registration certificates for all three phases as of March 13, 2026.
Project is strategically located at Plot No. R-12 of Hitech, Defense and Aerospace Park, Bengaluru.
Official market launch set for March 14, 2026, focusing on the domestic residential segment.
💼 Action for Investors
Investors should track the pre-sales velocity and booking numbers from this launch as they will be key drivers for future revenue and cash flows. The strategic location in a tech hub suggests strong potential demand.
Tata Motors Wins Pan-India Orders for Over 5,000 Buses from State Transport Undertakings
Tata Motors has secured cumulative orders for more than 5,000 buses and bus chassis from multiple State Transport Undertakings (STUs) across India. The orders were won through a competitive e-bidding process and include major states such as Maharashtra, Gujarat, Karnataka, and Telangana. The contract spans a wide range of models including Tata Magna, Starbus, and various LPO chassis variants for intercity and intracity operations. This significant win reinforces Tata Motors' leadership in the Indian commercial vehicle market and provides strong revenue visibility for its passenger mobility segment.
Key Highlights
Cumulative order win of over 5,000 buses and bus chassis from multiple State Transport Undertakings
Orders secured from 9 major entities including MSRTC, GSRTC, NWKRTC, and Haryana Roadways
Product range covers Tata Magna, Cityride, Starbus, and LPO 1618, 1622, and 1822 variants
Deployment to be carried out in phases as per agreements with respective STUs
Reinforces market leadership supported by a network of over 4,500 sales and service touchpoints
💼 Action for Investors
Investors should view this as a positive indicator of Tata Motors' continued dominance in the commercial vehicle space and its ability to win large-scale government contracts. Monitor the impact of these deliveries on the Commercial Vehicle segment's margins in the coming quarters.
Setubandhan Infra FY25 Results: Net Loss of ₹1.51 Cr Amid Ongoing Insolvency & Audit Qualifications
Setubandhan Infrastructure reported a net loss of ₹1.51 crore for the financial year ended March 31, 2025, on a total income of just ₹23.22 lakhs. The company is currently undergoing a Corporate Insolvency Resolution Process (CIRP), and the NCLT rejected its previously approved resolution plan in March 2025. Significant audit qualifications exist due to the non-availability of bank statements and financial records from the suspended management. An appeal against the NCLT's rejection is currently pending before the NCLAT, leaving the company's future uncertain.
Key Highlights
Reported a Net Loss of ₹1.51 crore for FY25 against a total income of ₹23.22 lakhs.
Total Assets and Liabilities are reported at ₹169.70 crore, though values are not revalued as per CIRP requirements.
The NCLT Mumbai Bench rejected the CoC-approved resolution plan on March 24, 2025.
Auditors issued a qualified opinion due to missing bank statements and lack of balance confirmations for assets/liabilities.
An appeal against the resolution plan rejection was filed with the NCLAT on July 09, 2025, and is currently sub-judice.
💼 Action for Investors
Investors should remain extremely cautious as the company is in a critical stage of insolvency with a rejected resolution plan. The lack of reliable financial data and ongoing legal battles at NCLAT suggest a high risk of total capital loss.